SLRN

Acelyrin, Inc. SLRN

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SLRN CRGX INXB CBLI TCRT CATB THRD SPPI MACK CELU
6M -27.94 % 17.63 % 13.94 % 0.00 % 9.80 % 0.00 % 53.71 % 31.75 % 14.39 % 28.21 %
YTD -31.21 % -70.30 % 13.94 % 0.00 % 36.55 % 0.00 % -51.27 % 167.97 % 13.79 % -9.09 %
1Y -42.96 % -81.53 % 13.94 % 252.18 % 30.58 % 0.00 % -60.15 % -10.87 % 21.55 % 16.96 %
3Y -87.39 % -69.24 % -90.67 % 56.93 % -98.49 % 0.00 % -68.35 % -75.65 % 136.64 % -91.45 %
5Y -87.39 % -69.24 % -90.67 % -2.46 % -99.19 % 0.00 % -68.35 % -95.47 % 240.34 % -98.06 %
10Y -87.39 % -69.24 % 1 486.00 % -90.73 % -99.85 % 0.00 % -68.35 % -86.62 % -74.80 % -97.96 %
From the beginning -87.39 % -69.24 % 1 486.00 % -97.01 % -99.89 % 0.00 % -68.35 % -99.25 % -68.13 % -97.96 %

Dividend

Third Harmonic Bio, Inc.

Spectrum Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc.